Bio Medica Laboratories Limited
ListedSMEHealthcare / Pharmaceuticals · NSE
Bio Medica Laboratories is a pharmaceutical company engaged in manufacturing parenteral formulations for both human and veterinary healthcare segments. The company produces a wide range of ethical drugs, generic medicines, and OTC products, primarily in liquid and dry powder injectable forms. Its portfolio includes 58 liquid injectables and 15 dry powder injectable products available in single-dose and multi-dose formats. Operating on a B2B contract manufacturing model, the company develops customized formulations according to client requirements. Supported by GMP and GLP certifications, Bio Medica runs two manufacturing facilities in Indore, Madhya Pradesh, focusing on quality production and pharmaceutical formulation development.
Price Band
₹132 – ₹139
Issue Size
₹377.20 L Cr
Lot Size
1000 shares
GMP
₹7
-5.0%
Est. Listing
₹132
at current GMP
Subscribed
2.31x
overall
Open
21 May 2026
Close
25 May 2026
Allotment
26 May 2026
Refund
27 May 2026
Demat Credit
28 May 2026
Listing
29 May 2026
Last updated 4 months ago
Official Registrar Verification
Bio Medica Laboratories Limited Allotment Status
Designated Registrar: Skyline Financial Services Private Limited
Allotment Date
26 May 2026
Basis finalization
Refunds Initiate
27 May 2026
Mandate release
Demat Credit
28 May 2026
Shares in demat
Listing Debut
29 May 2026
Trading begins
How to Check Bio Medica Laboratories Limited IPO Allotment Status
- Click the Check on Registrar button above to visit Skyline Financial Services Private Limited's allotment portal.
- Select Bio Medica Laboratories Limited from the dropdown company list.
- Choose your lookup mode: PAN Number, Application Number, or DP Client ID.
- Enter your details accurately and solve the Captcha code.
- Click Submit / Search to view the number of shares applied and allotted to you.
About Bio Medica Laboratories Limited Public Issue & Market Profile
Bio Medica Laboratories Limited is bringing an initial public offering (IPO) in the Healthcare / Pharmaceuticals sector with an aggregate issue size of ₹37,72,000 Crores. The shares are offered at a price band of ₹132 to ₹139 per equity share on NSE. Currently, investors are tracking the grey market premium (GMP) and institutional subscription multiples closely across BSE and NSE portals.
Public Issue & Allotment Procedure:
The public offer consists of a fresh issue and offer-for-sale structured under SEBI regulations. Bidding is open to Qualified Institutional Buyers (QIB), Non-Institutional Bidders (NII/HNI), and Retail Individual Investors (RII). Applications can be submitted online using ASBA or UPI mandate through certified stock brokers and net banking portals.
Official Allotment Timelines & Registrar Guidance:
Following the close of bidding on 2026-05-25, the basis of allotment is scheduled to be finalized on 2026-05-26. Investors can verify their application status online by submitting their PAN card number, Application Number, or DP Client ID on the registrar's official portal (Skyline Financial Services Private Limited) or the BSE allotment checking window.
Frequently Asked Questions
What if my name is not showing on the registrar portal?
Allotment records are updated in batches. If the status is not yet available, please wait a few hours until the basis of allotment is fully finalized.
How will I receive the refund if I don't get allotment?
Since funds are blocked under ASBA/UPI, the bank will automatically release the blocked hold on your funds upon receipt of revocation instructions from the sponsor bank.